USPTO serial 79323481
CANNABIXIR. FORGET PAIN. LIVE AGAIN.
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- STRUCK, ROBERT J
- Law office
- TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with CANNABIXIR. FORGET PAIN. LIVE AGAIN.?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals, medical or veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; dietary supplements for humans and animals; cachets for pharmaceutical purposes; dental preparations and articles, and medicated dentifrices; disinfectants and antiseptics; deodorizers and air purifying preparations; absorbent articles for personal hygiene; feminine hygiene products; medicated and sanitising soaps and detergents; diagnostic preparations and materials; natural remedies; plasters; materials for dressings; analgesics; antibacterial preparations; antibacterial pharmaceuticals; antimicrobial preparations; antioxidants; appetite stimulant preparations; medicines for human purposes; autonomic drugs for medical purposes; pharmaceutical preparations acting on the central nervous system; balms for medical purposes; balms for pharmaceutical purposes; sedatives; deodorants, other than for human beings or for animals; deodorising room sprays; dietetic preparations adapted for medical use; dragees [medicines]; drugs for medical purposes; elixirs [pharmaceutical preparations]; anti-inflammatories; preparations for making medicated beverages; extracts of medicinal plants; ground hempseed fiber for use as a dietary supplement; moisturising body lotion [pharmaceutical]; moisturising creams [pharmaceutical]; liquid herbal supplements; nutraceuticals for use as a dietary supplement; topical gels for medical and therapeutic use; medicinal drinks; skin care preparations for medical use; medicinal herbs in dried or preserved form; extracts of medicinal herbs; homeopathic pharmaceuticals; inhalants; capsules for medicines; chewing gum for medical purposes; germicides; medicinal herbs; smoking herbs for medical purposes; herbal extracts for medical purposes; herbal extracts for medicinal purposes; herbal beverages for medicinal use; herbal preparations for medical use; herbal teas for medicinal purposes; hempseed for pharmaceutical purposes; hempseed meal for pharmaceutical purposes; liniments; air deodorising preparations; hemp milk for pharmaceutical purposes; hemp oil for pharmaceutical purposes; medicated shampoos; medicinal sprays; medicinal tea; medicated food supplements; hempseed dietary supplements; hempseed oil dietary supplements; narcotics; nervines; nutraceutical preparations for therapeutic or medical purposes; medicinal oils; plant and herb extracts for medicinal use; pharmaceutical compositions; reagents for medical use; syrups for pharmaceutical purposes; all of the aforementioned goods in particular based on cannabis and in particular for the treatment of pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder (ADHD), bipolar disorder and post traumatic stress disorder (PTSD), diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, alzheimer's disease and autism, neuromuscular diseases, degenerative diseases and other medical conditions responsive to cannabinoids, including glaucoma, cancer and insomnia as well as side effects, including nausea, vomiting, lack of appetite and weight loss | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 21, 2023 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 27, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 27, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 12, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 22, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 22, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 27, 2022 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 27, 2022 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 27, 2022 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 10, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 14, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 14, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 11, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 10, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 3, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 24, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 29, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 25, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 22, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |